RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down

Dr. Reddy's Laboratories Limited (RDY) reported third-quarter fiscal 2025 earnings of 20 cents per American Depositary Share (ADS), which matched the Zacks Consensus Estimate. The company reported earnings of 19 cents per ADS in the year-ago quarter.See the Zacks Earnings Calendar to stay ahead of market-making news.Revenues grew 16% year over year to $977 million, which surpassed the Zacks Consensus Estimate of $875 million. The year-over-year improvement was primarily driven by growth in global generics r ...